A partner and past Chair of Heller Ehrman White & McAuliffe LLP, Julian Stern has been involved in the biotech industry since its beginnings, starting with his incorporation of ALZA Corporation in 1968. He has served on the board of directors of ALZA since its incorporation. In addition to his work for ALZA, he has been intimately involved in the organization of innovative biotechnology companies, including Cetus corporation, Affymax, Affymetrix and Maxygen. Along the way, he has devised creative development and licensing strategies and methods of financing for his clients that are now accepted industry practice. His pioneering legal work laid the foundation for Heller Ehrman's extensive life-sciences practice. Mr. Stern has worked for the San Francisco-based international law firm since 1956 and was the first attorney to staff its Silicon Valley office.

More information about Julian Stern can be found at his online biography on the Heller Ehrman web site.